CIK 0001820190
- Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-08 | Chun Jay Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-12-16 | Chun Jay Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-10-18 | Chun Jay Director | Purchase | +5,000 | $0.95 | $5K | 112,500 |
| 2024-06-20 | Chun Jay Director | Exercise or conversion | +5,000 | $1.41 | $7K | 107,500 |
| 2024-06-20 | Chun Jay Director | Exercise or conversion · Nonstatutory Stock Option (right to buy) | −5,000 | 245,000 | ||
| 2024-05-17 | Chun Jay Director | Purchase | +57,500 | $0.90 | $52K | 102,500 |
| 2023-10-04 | Chun Jay Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 |
Page 1 of 1 · 7 trades